Membranous glomerulonephritis in a patient with myelodysplastic syndrome-refractory cytopenia with multilineage dysplasia

被引:5
作者
Il Ko, Kwang [1 ]
Lee, Mi Jung [1 ]
Doh, Fa Mee [1 ]
Koo, Hyang Mo [1 ]
Kim, Chan Ho [1 ]
Shin, Dong Ho [1 ]
Oh, Hyung Jung [1 ]
Han, Seung Hyeok [1 ]
Kang, Shin-Wook [1 ]
Choi, Kyu Hun [1 ]
Yoo, Tae-Hyun [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, 134 Shinchon Dong, Seoul 120752, South Korea
关键词
Membranous glomerulonephritis; Myelodysplastic syndrome; Nephrotic syndrome; Refractory cytopenia with; multilineage dysplasia;
D O I
10.1016/j.krcp.2013.06.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A 74-year-old woman presented with edema in the lower extremities. Laboratory tests revealed anemia, thrombocytopenia, hypoalbuminemia, hypercholesterolemia, and nephrotic-range proteinuria. Myelodysplastic syndrome-refractory cytopenia with multi lineage dysplasia (MDS-RCMD) was confirmed by bone marrow biopsy. Renal biopsy demonstrated membranous glomerulonephritis (MGN), stage I. Based on these clinicopathologic results, she was diagnosed as having MGN with MDS-RCMD. This is a rare case report of MGN in a parient with MDS-RCMD featuring nephrotic syndrome. (C) 2013. The Korean Society of Nephrology. Published by Elsevier.
引用
收藏
页码:134 / 137
页数:4
相关论文
共 26 条
  • [1] Refractory cytopenia with multilineage dysplasia: Further characterization of an 'unclassifiable' myelodysplastic syndrome
    Rosati, S
    Mick, R
    Xu, F
    Stonys, E
    LeBeau, MM
    Larson, R
    Vardiman, JW
    LEUKEMIA, 1996, 10 (01) : 20 - 26
  • [2] A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q-syndrome from refractory anemia in primary myelodysplastic syndrome
    Cermák, J
    Michalová, K
    Brezinová, J
    Zemanová, Z
    LEUKEMIA RESEARCH, 2003, 27 (03) : 221 - 229
  • [3] Membranous glomerulonephritis and myelodysplastic syndrome
    Doukkali, O
    Tarrass, F
    Medkouri, G
    Fatihi, E
    Ramdani, B
    Zaid, D
    Azzouzi, S
    Sqalli, S
    NEPHROLOGIE, 2004, 25 (02): : 59 - 61
  • [4] Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia
    Majek, Pavel
    Reicheltova, Zuzana
    Suttnar, Jiri
    Cermak, Jaroslav
    Dyr, Jan E.
    PROTEOME SCIENCE, 2011, 9
  • [5] Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia
    Pavel Májek
    Zuzana Reicheltová
    Jiří Suttnar
    Jaroslav Čermák
    Jan E Dyr
    Proteome Science, 9
  • [6] Bone marrow blasts level predicts prognosis in patients with refractory cytopenia with multilineage dysplasia
    Wang, Hong
    Wang, Xiao-Qin
    Xu, Xiao-Ping
    Lin, Guo-Wei
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 83 (06) : 550 - 558
  • [7] SF3B1 Mutation but Not Ring Sideroblasts Identifies a Specific Group of Myelodysplastic SyndromeeRefractory Cytopenia With Multilineage Dysplasia
    Xiong, Bei
    Xue, Mei
    Yu, Yalan
    Wu, Sanyun
    Zuo, Xuelan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (05) : 329 - +
  • [8] Heterogeneity of Mesenchymal Stromal Cells in Myelodysplastic Syndrome-with Multilineage Dysplasia (MDS-MLD)
    Salar Abbas
    Sanjay Kumar
    Vivi M. Srivastava
    Marie Therese M.
    Sukesh C. Nair
    Aby Abraham
    Vikram Mathews
    Biju George
    Alok Srivastava
    Indian Journal of Hematology and Blood Transfusion, 2019, 35 : 223 - 232
  • [9] Heterogeneity of Mesenchymal Stromal Cells in Myelodysplastic Syndrome-with Multilineage Dysplasia (MDS-MLD)
    Abbas, Salar
    Kumar, Sanjay
    Srivastava, Vivi M.
    Therese, Marie M.
    Nair, Sukesh C.
    Abraham, Aby
    Mathews, Vikram
    George, Biju
    Srivastava, Alok
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2019, 35 (02) : 223 - 232
  • [10] Effect of Qinghuang Powder Combined with Bupi Yishen Decoction in Treating Patients with Refractory Cytopenia with Multilineage Dysplasia through Regulating DNA Methylation
    Zhou Qing-bing
    Yang Xiao-hong
    Wang Hong-zhi
    Wang De-xiu
    Xu Yong-gang
    Hu Xiao-mei
    Xu Feng-qin
    Ma Rou
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2019, 25 (05) : 354 - 359